SARS-CoV-2 infection of the oral cavity and saliva
2021 · Nature Medicine · 807 citations
https://doi.org/10.1038/s41591-021-01296-8
Y
Yu Mikami
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
137
Papers
2.5K
Citations
21
h-index
36
i10-index
Yu Mikami is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Hippo pathway signaling and YAP/TAZ & Chronic Obstructive Pulmonary Disease (COPD) Research. The author has an h-index of 21, co-authored 117 publications.
ORCID: 0000-0003-3262-2958Papers by this author
worksPrevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease
2022 · American Journal of Respiratory and Critical Care Medicine · 69 citations
https://doi.org/10.1164/rccm.202111-2606oc
Epithelial Expression of YAP and TAZ Is Sequentially Required in Lung Development
2019 · American Journal of Respiratory Cell and Molecular Biology · 50 citations
https://doi.org/10.1165/rcmb.2019-0218oc
Active mTOR in Lung Epithelium Promotes Epithelial–Mesenchymal Transition and Enhances Lung Fibrosis
2020 · American Journal of Respiratory Cell and Molecular Biology · 39 citations
https://doi.org/10.1165/rcmb.2019-0255oc
FOXL1 Regulates Lung Fibroblast Function Via Multiple Mechanisms
2020 · American Journal of Respiratory Cell and Molecular Biology · 37 citations
https://doi.org/10.1165/rcmb.2019-0396oc
An integrative transcriptome analysis reveals a functional role for thyroid transcription factor‐1 in small cell lung cancer
2018 · The Journal of Pathology · 22 citations
https://doi.org/10.1002/path.5109
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat